Loading clinical trials...
Loading clinical trials...
Severe Acute Respiratory Syndrome Coronavirus 2 of the Genus Betacoronavirus (SARSCoV2) Convalescent Plasma (CP) Expanded Access Protocol (EAP)
Conditions
Interventions
SARSCoV2 Convalescent Plasma
Locations
1
United States
AdventHealth Orlando
Orlando, Florida, United States
Last Updated
May 6, 2021
NCT06721949
NCT06082518
NCT07221162
NCT06631287
NCT06679140
NCT06417762
Lead Sponsor
AdventHealth
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions